[HTML][HTML] Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients
B Buijsers, C Yanginlar, ML Maciej-Hulme… - …, 2020 - thelancet.com
Abstract Coronavirus disease-2019 (COVID-19) is associated with severe inflammation in
mainly the lung, and kidney. Reports suggest a beneficial effect of the use of heparin/low …
mainly the lung, and kidney. Reports suggest a beneficial effect of the use of heparin/low …
[引用][C] Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients
B Buijsers, C Yanginlar, ML Maciej-Hulme, Q de Mast… - eBioMedicine, 2020 - cir.nii.ac.jp
Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
[PDF][PDF] Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients
B Buijsers, C Yanginlar, ML Maciej Hulme, Q Mast… - 2020 - repository.ubn.ru.nl
Coronavirus disease-2019 (COVID-19) is associated with severe inflammation in mainly the
lung, and kidney. Reports suggest a beneficial effect of the use of heparin/low molecular …
lung, and kidney. Reports suggest a beneficial effect of the use of heparin/low molecular …
[HTML][HTML] Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients
B Buijsers, C Yanginlar, ML Maciej-Hulme… - …, 2020 - ncbi.nlm.nih.gov
Abstract Coronavirus disease-2019 (COVID-19) is associated with severe inflammation in
mainly the lung, and kidney. Reports suggest a beneficial effect of the use of heparin/low …
mainly the lung, and kidney. Reports suggest a beneficial effect of the use of heparin/low …
Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients
B Buijsers, C Yanginlar, ML Maciej-Hulme… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Coronavirus disease-2019 (COVID-19) is associated with severe inflammation in mainly the
lung, and kidney. Reports suggest a beneficial effect of the use of heparin/low molecular …
lung, and kidney. Reports suggest a beneficial effect of the use of heparin/low molecular …
Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients.
B Buijsers, C Yanginlar, ML Maciej-Hulme… - Ebiomedicine, 2020 - europepmc.org
Abstract Coronavirus disease-2019 (COVID-19) is associated with severe inflammation in
mainly the lung, and kidney. Reports suggest a beneficial effect of the use of heparin/low …
mainly the lung, and kidney. Reports suggest a beneficial effect of the use of heparin/low …
Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients
B Buijsers, C Yanginlar, ML Maciej-Hulme… - 2020 - expeditiorepositorio.utadeo.edu.co
Coronavirus disease-2019 (COVID-19) is associated with severe inflammation in mainly the
lung, and kidney. Reports suggest a beneficial effect of the use of heparin/low molecular …
lung, and kidney. Reports suggest a beneficial effect of the use of heparin/low molecular …
[HTML][HTML] Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients
B Buijsers, C Yanginlar, ML Maciej-Hulme, Q de Mast… - eBioMedicine, 2020 - Elsevier
Abstract Coronavirus disease-2019 (COVID-19) is associated with severe inflammation in
mainly the lung, and kidney. Reports suggest a beneficial effect of the use of heparin/low …
mainly the lung, and kidney. Reports suggest a beneficial effect of the use of heparin/low …
[PDF][PDF] Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients
B Buijsers, C Yanginlar… - … in inflammation and …, 2023 - repository.ubn.ru.nl
Abstract Coronavirus disease-2019 (COVID-19) is associated with severe inflammation in
mainly the lung, and kidney. Reports suggest a beneficial effect of the use of heparin/low …
mainly the lung, and kidney. Reports suggest a beneficial effect of the use of heparin/low …